Glibenclamide/metformin superior to monotherapies as initial therapy

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1409, 2003-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination of glibenclamide–metformin HCl for the treatment of type 2 diabetes mellitus

By Lamos Elizabeth Mary   Stein Stephanie Aleskow   Davis Stephen N  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 17, 2012-12 ,pp. : 2545-2554

Informa Healthcare

Access to resources Recommend Favorite

Glibenclamide/metformin overdose: Hypoglycaemia, and lactic acidosis leading to other toxicities: case report

By  

Reactions Weekly, Vol. 1, Iss. 1394, 2012-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Penmix insulin superior to glibenclamide in elderly patients

By  

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Candesartan cilexetil + lisinopril superior to monotherapies?

By  

Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Tolerability Profile of Metformin/Glibenclamide Combination Tablets (Glucovance®): A New Treatment for the Management of Type 2 Diabetes Mellitus

By Jaime A. Davidson  

Drug Safety, Vol. 27, Iss. 15, 2004-01 ,pp. : 1205-1216

Adis International

Access to resources Recommend Favorite